Managing nanotech risks - real and perceived
Companies hoping to capitalise on the multi-billion dollar nanotechnology market cannot afford to wait for regulators to reassure the public of their products’ safety, warns Roz Bulleid
Companies hoping to capitalise on the multi-billion dollar nanotechnology market cannot afford to wait for regulators to reassure the public of their products’ safety, warns Roz Bulleid